FDA Grants Orphan Drug Designation to Lipiodol®

22.10.2013 16:53

Guerbet LLC, USA (October 21, 2013)

Guerbet, a pioneer in the field of contast agents with mre than 80 years of experience, announced that it ha been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Developement (OOPD) for Lipiodol (Ethiodized Oil) Injection for management of patients with known hepatocellular carcinoma (HCC).

Click here to read the press release